9999999997-18-000375.txt : 20180112 9999999997-18-000375.hdr.sgml : 20180112 20180112163351 ACCESSION NUMBER: 9999999997-18-000375 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180112 DATE AS OF CHANGE: 20180112 ACTION DATE: 20180112 RECEIVED DATE: 20180112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Athenex, Inc. CENTRAL INDEX KEY: 0001300699 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 431985966 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-38112 FILM NUMBER: 18526298 BUSINESS ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 BUSINESS PHONE: 716-898-8625 MAIL ADDRESS: STREET 1: 1001 MAIN STREET STREET 2: SUITE 600 CITY: BUFFALO STATE: NY ZIP: 14203 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20131223 FORMER COMPANY: FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC DATE OF NAME CHANGE: 20040817 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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end